JP Morgan Chase
RPID icon

JP Morgan Chase’s Rapid Micro Biosystems RPID Stock Holding History

JP Morgan Chase’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$189 Hold
109
– – ﹤0.01% 7501
2026
Q1 		$242 Hold
109
– – ﹤0.01% 7235
2025
Q4 		$316 Hold
109
– – ﹤0.01% 7119
2025
Q3 		$364 Hold
109
– – ﹤0.01% 7075
2025
Q2 		$376 Hold
109
– – ﹤0.01% 6726
2025
Q1 		$288 Sell
109
-48
-31% -$109 ﹤0.01% 6757
2024
Q4 		$141 Sell
157
-321,173
-100% -$323K ﹤0.01% 6961
2024
Q3 		$286K Sell
321,330
-252,598
-44% -$196K ﹤0.01% 5232
2024
Q2 		$379K Sell
573,928
-48,903
-8% -$41.8K ﹤0.01% 4832
2024
Q1 		$604K Sell
622,831
-128,481
-17% -$125K ﹤0.01% 4675
2023
Q4 		$556K Sell
751,312
-682,916
-48% -$699K ﹤0.01% 4724
2023
Q3 		$1.55M Sell
1,434,228
-1,479
-0.1% -$1.47K ﹤0.01% 3746
2023
Q2 		$1.44M Sell
1,435,707
-19,454
-1% -$19.7K ﹤0.01% 3787
2023
Q1 		$1.91M Buy
1,455,161
+1,453,885
+113,941% +$1.89M ﹤0.01% 3575
2022
Q4 		$1K Sell
1,276
-1,414,867
-100% -$3.42M ﹤0.01% 6433
2022
Q3 		$4.57M Sell
1,416,143
-64,792
-4% -$251K ﹤0.01% 2829
2022
Q2 		$6.37M Sell
1,480,935
-159,668
-10% -$743K ﹤0.01% 2562
2022
Q1 		$11.1M Sell
1,640,603
-145,170
-8% -$1.07M ﹤0.01% 2262
2021
Q4 		$19M Buy
1,785,773
+101,541
+6% +$1.59M ﹤0.01% 1871
2021
Q3 		$31.1M Buy
+1,684,232
New +$34.8M ﹤0.01% 1454

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $8.55M AUM 12.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EFA
Evernest Financial Advisors Carmel, Indiana $478M AUM 24% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

JP Morgan Chase's RPID Position: Q2 2026 in Review

JP Morgan Chase held its Rapid Micro Biosystems (RPID) position steady in Q2 2026 at 109 shares worth $189. The position accounts for ﹤0.01% of the portfolio, ranked #7501.

JP Morgan Chase first reported a position in RPID in Q3 2021 and has held it in 20 quarters since. The position peaked at $31.1M in Q3 2021. 34 funds tracked by Wall St. Rank hold RPID as of Q2 2026.

  • JP Morgan Chase held 109 shares of Rapid Micro Biosystems worth $189 as of Q2 2026.
  • JP Morgan Chase left its Rapid Micro Biosystems share count unchanged in Q2 2026.
  • Rapid Micro Biosystems made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7501 holding.
  • JP Morgan Chase first reported a position in Rapid Micro Biosystems in Q3 2021 and has held it in 20 quarters since.
  • JP Morgan Chase's Rapid Micro Biosystems position peaked at $31.1M in Q3 2021.
  • 34 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.